Ghrelin in gastrointestinal disease

Molecular and Cellular Endocrinology

Volumn 340, Issue 1, 2011, Pages 35-43

  Jeffery, Penny ^a   McDonald, Victoria ^a   Tippett, Emma ^a   McGuckin, Michael ^a  

^a MATER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Cachexia; Coeliac disease; Gastritis; Gastrointestinal; Ghrelin; GOAT; H. pylori; IBD; MCT; Motility

Indexed keywords

ACYLTRANSFERASE; C REACTIVE PROTEIN; GHRELIN; GHRELIN O ACYLTRANSFERASE; GROWTH HORMONE SECRETAGOGUE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; ULIMORELIN; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; APPETITE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELIAC DISEASE; COGNITION; COLITIS; DIARRHEA; DIGESTIVE SYSTEM CANCER; DRUG EFFICACY; DRUG POTENCY; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; FOOD INTAKE; GASTRITIS; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HORMONE ACTION; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; IMMUNITY; INSULIN RELEASE; INSULIN SENSITIVITY; IRRITABLE COLON; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; SMALL INTESTINE; STOMACH EMPTYING; STOMACH MUCOSA; STOMACH PARESIS; STOMACH PROTECTION;

ACYLTRANSFERASES; ANIMALS; GASTRIC MUCOSA; GASTROINTESTINAL DISEASES; GHRELIN; HUMANS;

EID: 79958142841     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.03.002     Document Type: Review

References (155)

1. Adami M., Pozzoli C., Leurs R., Stark H., Coruzzi G. Histamine H receptors are involved in the protective effect of ghrelin against HCl-induced gastric damage in rats. Pharmacology 2010, 86:259-266.
2. Al-Massadi O., Crujeiras A.B., Gonzalez R.C., Pardo M., Dieguez C., Casanueva F.F., Seoane L.M. Age, sex, and lactating status regulate ghrelin secretion and GOAT mRNA levels from isolated rat stomach. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E341-E350.
3. Alexandridis E., Zisimopoulos A., Liratzopoulos N., Katsos I., Manolas K., Kouklakis G. Obestatin/ghrelin ratio: a new activity index in inflammatory bowel diseases. Inflamm. Bowel Dis. 2009, 15:1557-1561.
4. Amedei A., Bergman M.P., Appelmelk B.J., Azzurri A., Benagiano M., Tamburini C., van der Zee R., Telford J.L., Vandenbroucke-Grauls C.M., D'Elios M.M., Del Prete G. Molecular mimicry between Helicobacter pylori antigens and H+, K+: adenosine triphosphatase in human gastric autoimmunity. J. Exp. Med. 2003, 198:1147-1156.
5. Andrews E.B., Eaton S.C., Hollis K.A., Hopkins J.S., Ameen V., Hamm L.R., Cook S.F., Tennis P., Mangel A.W. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment. Pharmacol. Ther. 2005, 22:935-942.
6. Andrews Z.B., Liu Z.W., Walllingford N., Erion D.M., Borok E., Friedman J.M., Tschop M.H., Shanabrough M., Cline G., Shulman G.I., Coppola A., Gao X.B., Horvath T.L., Diano S. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 2008, 454:846-851.
7. Ashitani J., Matsumoto N., Nakazato M. Effect of octanoic acid-rich formula on plasma ghrelin levels in cachectic patients with chronic respiratory disease. Nutr. J. 2009, 8:25.
8. Ates Y., Degertekin B., Erdil A., Yaman H., Dagalp K. Serum ghrelin levels in inflammatory bowel disease with relation to disease activity and nutritional status. Dig. Dis. Sci. 2008, 53:2215-2221.
9. Aydin S., Ozercan I.H., Dagli F., Dogru O., Celebi S., Akin O., Guzel S.P. Ghrelin immunohistochemistry of gastric adenocarcinoma and mucoepidermoid carcinoma of salivary gland. Biotech. Histochem. 2005, 80:163-168.
10. Ballinger A.B., Camacho-Hubner C., Croft N.M. Growth failure and intestinal inflammation. QJM 2001, 94:121-125.
11. Bennett E.J., Tennant C.C., Piesse C., Badcock C.A., Kellow J.E. Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut 1998, 43:256-261.
12. Bossenmeyer-Pourie C., Blaise S., Pourie G., Tomasetto C., Audonnet S., Ortiou S., Koziel V., Rio M.C., Daval J.L., Gueant J.L., Beck B. Methyl donor deficiency affects fetal programming of gastric ghrelin cell organization and function in the rat. Am. J. Pathol. 2010, 176:270-277.
13. Brzozowski T., Konturek P.C., Konturek S.J., Kwiecien S., Drozdowicz D., Bielanski W., Pajdo R., Ptak A., Nikiforuk A., Pawlik W.W., Hahn E.G. Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Regul. Pept. 2004, 120:39-51.
14. Camilleri M., Papathanasopoulos A., Odunsi S.T. Actions and therapeutic pathways of ghrelin for gastrointestinal disorders. Nat. Rev. Gastroenterol. Hepatol. 2009, 6:343-352.
15. Campana D., Nori F., Pagotto U., De Iasio R., Morselli-Labate A.M., Pasquali R., Corinaldesi R., Tomassetti P. Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis. Clin. Endocrinol. (Oxf) 2007, 67:761-766.
16. Capristo E., Farnetti S., Mingrone G., Certo M., Greco A.V., Addolorato G., Gasbarrini G. Reduced plasma ghrelin concentration in celiac disease after gluten-free diet treatment. Scand. J. Gastroenterol. 2005, 40:430-436.
17. Catassi C., Fasano A. Celiac disease as a cause of growth retardation in childhood. Curr. Opin. Pediatr. 2004, 16:445-449.
18. Checchi S., Montanaro A., Pasqui L., Ciuoli C., Cevenini G., Sestini F., Fioravanti C., Pacini F. Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies. J. Clin. Endocrinol. Metab. 2007, 92:4346-4351.
19. Choe Y.H., Jin D.K., Kim S.E., Song S.Y., Paik K.H., Park H.Y., Oh Y.J., Kim A.H., Kim J.S., Kim C.W., Chu S.H., Kwon E.K., Lee K.H. Hyperghrelinemia does not accelerate gastric emptying in Prader-Willi syndrome patients. J. Clin. Endocrinol. Metab. 2005, 90:3367-3370.
20. Claeys D., Faller G., Appelmelk B.J., Negrini R., Kirchner T. The gastric H+, K+: ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology 1998, 115:340-347.
21. Corbetta S., Peracchi M., Cappiello V., Lania A., Lauri E., Vago L., Beck-Peccoz P., Spada A. Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma. J. Clin. Endocrinol. Metab. 2003, 88:3117-3120.
22. Cripps A.W., Sutton P., Beagley K., Robertson S., Dunkley M. Mucosal immunology down under: Special Interest Group in Mucosal Immunology workshop, Australasian Society for Immunology, Sydney, Australia, 2 December 2007. Immunol. Cell Biol. 2008, 86:557-561.
23. Cummings D.E., Clement K., Purnell J.Q., Vaisse C., Foster K.E., Frayo R.S., Schwartz M.W., Basdevant A., Weigle D.S. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat. Med. 2002, 8:643-644.
24. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., Weigle D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50:1714-1719.
25. D'Onghia V., Leoncini R., Carli R., Santoro A., Giglioni S., Sorbellini F., Marzocca G., Bernini A., Campagna S., Marinello E., Vannoni D. Circulating gastrin and ghrelin levels in patients with colorectal cancer: correlation with tumour stage, Helicobacter pylori infection and BMI. Biomed. Pharmacother. 2007, 61:137-141.
26. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M.S., Suganuma T., Matsukura S., Kangawa K., Nakazato M. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000, 141:4255-4261.
27. Date Y., Nakazato M., Murakami N., Kojima M., Kangawa K., Matsukura S. Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem. Biophys. Res. Commun. 2001, 280:904-907.
28. De Smet B., Depoortere I., Moechars D., Swennen Q., Moreaux B., Cryns K., Tack J., Buyse J., Coulie B., Peeters T.L. Energy homeostasis and gastric emptying in ghrelin knockout mice. J. Pharmacol. Exp. Ther. 2006, 316:431-439.
29. De Smet B., Mitselos A., Depoortere I. Motilin and ghrelin as prokinetic drug targets. Pharmacol. Ther. 2009, 123:207-223.
30. De Smet B., Thijs T., Moechars D., Colsoul B., Polders L., Ver Donck L., Coulie B., Peeters T.L., Depoortere I. Endogenous and exogenous ghrelin enhance the colonic and gastric manifestations of dextran sodium sulphate-induced colitis in mice. Neurogastroenterol. Motil. 2009, 21:59-70.
31. Delhanty P.J., Sun Y., Visser J.A., van Kerkwijk A., Huisman M., van Ijcken W.F., Swagemakers S., Smith R.G., Themmen A.P., van der Lely A.J. Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice. PLoS One 2010, 5:e11749.
32. DelParigi A., Tschop M., Heiman M.L., Salbe A.D., Vozarova B., Sell S.M., Bunt J.C., Tataranni P.A. High circulating ghrelin: a potential cause for hyperphagia and obesity in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 2002, 87:5461-5464.
33. di Mario F., Cavallaro L.G. Non-invasive tests in gastric diseases. Dig. Liver Dis. 2008, 40:523-530.
34. Dieleman L.A., Palmen M.J., Akol H., Bloemena E., Pena A.S., Meuwissen S.G., Van Rees E.P. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin. Exp. Immunol. 1998, 114:385-391.
35. Dixit V.D., Schaffer E.M., Pyle R.S., Collins G.D., Sakthivel S.K., Palaniappan R., Lillard J.W., Taub D.D. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J. Clin. Invest. 2004, 114:57-66.
36. Dixit V.D., Yang H., Cooper-Jenkins A., Giri B.B., Patel K., Taub D.D. Reduction of T cell-derived ghrelin enhances proinflammatory cytokine expression: implications for age-associated increases in inflammation. Blood 2009, 113:5202-5205.
37. Dixit V.D., Yang H., Sun Y., Weeraratna A.T., Youm Y.H., Smith R.G., Taub D.D. Ghrelin promotes thymopoiesis during aging. J. Clin. Invest. 2007, 117:2778-2790.
38. Ejskjaer N., Dimcevski G., Wo J., Hellstrom P.M., Gormsen L.C., Sarosiek I., Softeland E., Nowak T., Pezzullo J.C., Shaughnessy L., Kosutic G., McCallum R. Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study. Neurogastroenterol. Motil. 2010, 22:e1069-e1281.
39. Ejskjaer N., Vestergaard E.T., Hellstrom P.M., Gormsen L.C., Madsbad S., Madsen J.L., Jensen T.A., Pezzullo J.C., Christiansen J.S., Shaughnessy L., Kosutic G. Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis. Aliment. Pharmacol. Ther. 2009, 29:1179-1187.
40. El-Salhy M., Lillebo E., Reinemo A., Salmelid L. Ghrelin in patients with irritable bowel syndrome. Int. J. Mol. Med. 2009, 23:703-707.
41. El-Salhy M., Vaali K., Dizdar V., Hausken T. Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome. Dig. Dis. Sci. 2010, 55:3508-3513.
42. Fraser G.L., Hoveyda H.R., Tannenbaum G.S. Pharmacological demarcation of the growth hormone, gut motility and feeding effects of ghrelin using a novel ghrelin receptor agonist. Endocrinology 2008, 149:6280-6288.
43. Fujino K., Inui A., Asakawa A., Kihara N., Fujimura M., Fujimiya M. Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J. Physiol. 2003, 550:227-240.
44. Garcia J.M., Garcia-Touza M., Hijazi R.A., Taffet G., Epner D., Mann D., Smith R.G., Cunningham G.R., Marcelli M. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J. Clin. Endocrinol. Metab. 2005, 90:2920-2926.
45. Ghe C., Cassoni P., Catapano F., Marrocco T., Deghenghi R., Ghigo E., Muccioli G., Papotti M. The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. Endocrinology 2002, 143:484-491.
46. Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., Bhattacharya S., Carpenter R., Grossman A.B., Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab. 2002, 87:2988.
47. Gokcel A., Gumurdulu Y., Kayaselcuk F., Serin E., Ozer B., Ozsahin A.K., Guvener N. Helicobacter pylori has no effect on plasma ghrelin levels. Eur. J. Endocrinol. 2003, 148:423-426.
48. Gonzalez-Rey E., Chorny A., Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 2006, 130:1707-1720.
49. Goodyear S., Arasaradnam R.P., Quraishi N., Mottershead M., Nwokolo C.U. Acylated and des acyl ghrelin in human portal and systemic circulations. Mol. Biol. Rep. 2010, 37:3697-3701.
50. Gourcerol G., St-Pierre D.H., Tache Y. Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)?. Regul. Pept. 2007, 141:1-7.
51. Green P.H., Fleischauer A.T., Bhagat G., Goyal R., Jabri B., Neugut A.I. Risk of malignancy in patients with celiac disease. Am. J. Med. 2003, 115:191-195.
52. Gronberg M., Tsolakis A.V., Magnusson L., Janson E.T., Saras J. Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands. J. Histochem. Cytochem. 2008, 56:793-801.
53. Gualillo O., Caminos J., Blanco M., Garcia-Caballero T., Kojima M., Kangawa K., Dieguez C., Casanueva F. Ghrelin, a novel placental-derived hormone. Endocrinology 2001, 142:788-794.
54. Gutierrez J.A., Solenberg P.J., Perkins D.R., Willency J.A., Knierman M.D., Jin Z., Witcher D.R., Luo S., Onyia J.E., Hale J.E. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:6320-6325.
55. Han X., Benight N., Osuntokun B., Loesch K., Frank S.J., Denson L.A. Tumour necrosis factor alpha blockade induces an anti-inflammatory growth hormone signalling pathway in experimental colitis. Gut 2007, 56:73-81.
56. Hattori N. Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system. Growth Horm. IGF Res. 2009, 19:187-197.
57. Holst B., Egerod K.L., Schild E., Vickers S.P., Cheetham S., Gerlach L.O., Storjohann L., Stidsen C.E., Jones R., Beck-Sickinger A.G., Schwartz T.W. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 2007, 148:13-20.
58. Horvath T.L., Diano S., Sotonyi P., Heiman M., Tschop M. Minireview: ghrelin and the regulation of energy balance - a hypothalamic perspective. Endocrinology 2001, 142:4163-4169.
59. Hosoda H., Kojima M., Matsuo H., Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem. Biophys. Res. Commun. 2000, 279:909-913.
60. Hosomi S., Oshitani N., Kamata N., Sogawa M., Yamagami H., Watanabe K., Tominaga K., Watanabe T., Fujiwara Y., Maeda K., Hirakawa K., Arakawa T. Phenotypical and functional study of ghrelin and its receptor in the pathogenesis of Crohn's disease. Inflamm. Bowel Dis. 2008, 14:1205-1213.
61. Huang Q., Fan Y.Z., Ge B.J., Zhu Q., Tu Z.Y. Circulating ghrelin in patients with gastric or colorectal cancer. Dig. Dis. Sci. 2007, 52:803-809.
62. Inhoff T., Monnikes H., Noetzel S., Stengel A., Goebel M., Dinh Q.T., Riedl A., Bannert N., Wisser A.S., Wiedenmann B., Klapp B.F., Tache Y., Kobelt P. Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats. Peptides 2008, 29:2159-2168.
63. Isomoto H., Nakazato M., Ueno H., Date Y., Nishi Y., Mukae H., Mizuta Y., Ohtsuru A., Yamashita S., Kohno S. Low plasma ghrelin levels in patients with Helicobacter pylori-associated gastritis. Am. J. Med. 2004, 117:429-432.
64. Isomoto H., Ueno H., Saenko V.A., Mondal M.S., Nishi Y., Kawano N., Ohnita K., Mizuta Y., Ohtsuru A., Yamashita S., Nakazato M., Kohno S. Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans. Am. J. Gastroenterol. 2005, 100:1711-1720.
65. Jang E.J., Park S.W., Park J.S., Park S.J., Hahm K.B., Paik S.Y., Sin M.K., Lee E.S., Oh S.W., Park C.Y., Baik H.W. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease. J. Gastroenterol. Hepatol. 2008, 23(Suppl. 2):S278-S285.
66. Jarocka-Cyrta E., Kasacka I., Kaczmarski M. The ghrelin-positive cells number is increased in duodenum in children with celiac disease. J. Endocrinol. Invest. 2010, 33:165-170.
67. Jeffery P.L., Murray R.E., Yeh A.H., McNamara J.F., Duncan R.P., Francis G.D., Herington A.C., Chopin L.K. Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocr. Relat. Cancer 2005, 12:839-850.
68. Jeon T.Y., Lee S., Kim H.H., Kim Y.J., Son H.C., Kim D.H., Sim M.S. Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer. J. Clin. Endocrinol. Metab. 2004, 89:5392-5396.
69. Kanazawa M., Palsson O.S., Thiwan S.I., Turner M.J., van Tilburg M.A., Gangarosa L.M., Chitkara D.K., Fukudo S., Drossman D.A., Whitehead W.E. Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits. Am. J. Gastroenterol. 2008, 103:2550-2561.
70. Karmiris K., Koutroubakis I.E., Xidakis C., Polychronaki M., Voudouri T., Kouroumalis E.A. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm. Bowel Dis. 2006, 12:100-105.
71. Kawaguchi H., Haruma K., Komoto K., Yoshihara M., Sumii K., Kajiyama G. Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am. J. Gastroenterol. 1996, 91:959-962.
72. Kawamura K., Sato N., Fukuda J., Kodama H., Kumagai J., Tanikawa H., Nakamura A., Honda Y., Sato T., Tanaka T. Ghrelin inhibits the development of mouse preimplantation embryos in vitro. Endocrinology 2003, 144:2623-2633.
73. Kawashima J., Ohno S., Sakurada T., Takabayashi H., Kudo M., Ro S., Kato S., Yakabi K. Circulating acylated ghrelin level decreases in accordance with the extent of atrophic gastritis. J. Gastroenterol. 2009, 44:1046-1054.
74. Khan W.I., Ghia J.E. Gut hormones: emerging role in immune activation and inflammation. Clin. Exp. Immunol. 2010, 161:19-27.
75. Kirchner H., Gutierrez J.A., Solenberg P.J., Pfluger P.T., Czyzyk T.A., Willency J.A., Schurmann A., Joost H.G., Jandacek R.J., Hale J.E., Heiman M.L., Tschop M.H. GOAT links dietary lipids with the endocrine control of energy balance. Nat. Med. 2009, 15:741-745.
76. Kodama T., Ashitani J., Matsumoto N., Kangawa K., Nakazato M. Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection. Pulm. Pharmacol. Ther. 2008, 21:774-779.
77. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
78. Kono H., Fujii H., Ishii K., Hosomura N., Ogiku M. Dietary medium-chain triglycerides prevent chemically induced experimental colitis in rats. Transl. Res. 2010, 155:131-141.
79. Kono H., Fujii H., Ogiku M., Tsuchiya M., Ishii K., Hara M. Enteral diets enriched with medium-chain triglycerides and N-3 fatty acids prevent chemically induced experimental colitis in rats. Transl. Res. 2010, 156:282-291.
80. Konturek P.C., Brzozowski T., Engel M., Burnat G., Gaca P., Kwiecien S., Pajdo R., Konturek S.J. Ghrelin ameliorates colonic inflammation. Role of nitric oxide and sensory nerves. J. Physiol. Pharmacol. 2009, 60:41-47.
81. Konturek P.C., Brzozowski T., Pajdo R., Nikiforuk A., Kwiecien S., Harsch I., Drozdowicz D., Hahn E.G., Konturek S.J. Ghrelin: a new gastroprotective factor in gastric mucosa. J. Physiol. Pharmacol. 2004, 55:325-336.
82. Kuipers E.J., Uyterlinde A.M., Pena A.S., Roosendaal R., Pals G., Nelis G.F., Festen H.P., Meuwissen S.G. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995, 345:1525-1528.
83. Lahner E., Annibale B. Pernicious anemia: new insights from a gastroenterological point of view. World J. Gastroenterol. 2009, 15:5121-5128.
84. Lanzini A., Magni P., Petroni M.L., Motta M., Lanzarotto F., Villanacci V., Amato M., Mora A., Bertolazzi S., Benini F., Ricci C. Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet. Aliment. Pharmacol. Ther. 2006, 23:907-913.
85. Lee E.S., Yoon Y.S., Park C.Y., Kim H.S., Um T.H., Baik H.W., Jang E.J., Lee S., Park H.S., Oh S.W. Eradication of Helicobacter pylori increases ghrelin mRNA expression in the gastric mucosa. J. Korean Med. Sci. 2010, 25:265-271.
86. Lee H.M., Wang G., Englander E.W., Kojima M., Greeley G.H. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 2002, 143:185-190.
87. LeSauter J., Hoque N., Weintraub M., Pfaff D.W., Silver R. Stomach ghrelin-secreting cells as food-entrainable circadian clocks. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13582-13587.
88. Levin F., Edholm T., Schmidt P.T., Gryback P., Jacobsson H., Degerblad M., Hoybye C., Holst J.J., Rehfeld J.F., Hellstrom P.M., Naslund E. Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J. Clin. Endocrinol. Metab. 2006, 91:3296-3302.
89. Longstreth G.F., Thompson W.G., Chey W.D., Houghton L.A., Mearin F., Spiller R.C. Functional bowel disorders. Gastroenterology 2006, 130:1480-1491.
90. Malandrino N., Capristo E., Farnetti S., Leggio L., Abenavoli L., Addolorato G., Gasbarrini G. Metabolic and nutritional features in adult celiac patients. Dig. Dis. 2008, 26:128-133.
91. Mane J., Pedrosa E., Loren V., Ojanguren I., Fluvia L., Cabre E., Rogler G., Gassull M.A. Partial replacement of dietary (n-6) fatty acids with medium-chain triglycerides decreases the incidence of spontaneous colitis in interleukin-10-deficient mice. J. Nutr. 2009, 139:603-610.
92. Marshall B.J. The Campylobacter pylori story. Scand. J. Gastroenterol. 1988, (Suppl. 146):58-66.
93. Masuda Y., Tanaka T., Inomata N., Ohnuma N., Tanaka S., Itoh Z., Hosoda H., Kojima M., Kangawa K. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem. Biophys. Res. Commun. 2000, 276:905-908.
94. Moreno M., Chaves J.F., Sancho-Bru P., Ramalho F., Ramalho L.N., Mansego M.L., Ivorra C., Dominguez M., Conde L., Millan C., Mari M., Colmenero J., Lozano J.J., Jares P., Vidal J., Forns X., Arroyo V., Caballeria J., Gines P., Bataller R. Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans. Hepatology 2010, 51:974-985.
95. Morris G.P., Beck P.L., Herridge M.S., Depew W.T., Szewczuk M.R., Wallace J.L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989, 96:795-803.
96. Mottershead M., Karteris E., Barclay J.Y., Suortamo S., Newbold M., Randeva H., Nwokolo C.U. Immunohistochemical and quantitative mRNA assessment of ghrelin expression in gastric and oesophageal adenocarcinoma. J. Clin. Pathol. 2007, 60:405-409.
97. Murata M., Okimura Y., Iida K., Matsumoto M., Sowa H., Kaji H., Kojima M., Kangawa K., Chihara K. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J. Biol. Chem. 2002, 277:5667-5674.
98. Murray C.D., Martin N.M., Patterson M., Taylor S.A., Ghatei M.A., Kamm M.A., Johnston C., Bloom S.R., Emmanuel A.V. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 2005, 54:1693-1698.
99. Neary N.M., Small C.J., Wren A.M., Lee J.L., Druce M.R., Palmieri C., Frost G.S., Ghatei M.A., Coombes R.C., Bloom S.R. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab. 2004, 89:2832-2836.
100. Nishi Y., Hiejima H., Hosoda H., Kaiya H., Mori K., Fukue Y., Yanase T., Nawata H., Kangawa K., Kojima M. Ingested medium-chain fatty acids are directly utilized for the acyl modification of ghrelin. Endocrinology 2005, 146:2255-2264.
101. Nonoshita A., Nishi Y., Takushima S., Oshima M., Hosoda H., Kangawa K., Kojima M., Mifune H., Tanaka E., Hori D., Kamura T. Dynamics of placental ghrelin production and its receptor expression in a Dahl salt-sensitive rat model of intrauterine growth restriction. Placenta 2010, 31:358-364.
102. Nwokolo C.U., Freshwater D.A., O'Hare P., Randeva H.S. Plasma ghrelin following cure of Helicobacter pylori. Gut 2003, 52:637-640.
103. Ohman L., Simren M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat. Rev. Gastroenterol. Hepatol. 2010, 7:163-173.
104. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990, 98:694-702.
105. Osawa H., Nakazato M., Date Y., Kita H., Ohnishi H., Ueno H., Shiiya T., Satoh K., Ishino Y., Sugano K. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J. Clin. Endocrinol. Metab. 2005, 90:10-16.
106. Papotti M., Cassoni P., Volante M., Deghenghi R., Muccioli G., Ghigo E. Ghrelin-producing endocrine tumors of the stomach and intestine. J. Clin. Endocrinol. Metab. 2001, 86:5052-5059.
107. Parkes G.C., Brostoff J., Whelan K., Sanderson J.D. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment. Am. J. Gastroenterol. 2008, 103:1557-1567.
108. Parsonnet J. The incidence of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 1995, 9(Suppl. 2):45-51.
109. Peracchi M., Bardella M.T., Caprioli F., Massironi S., Conte D., Valenti L., Ronchi C., Beck-Peccoz P., Arosio M., Piodi L. Circulating ghrelin levels in patients with inflammatory bowel disease. Gut 2006, 55:432-433.
110. Peracchi M., Conte D., Terrani C., Pizzinelli S., Gebbia C., Cappiello V., Spada A., Bardella M.T. Circulating ghrelin levels in celiac patients. Am. J. Gastroenterol. 2003, 98:2474-2478.
111. Reimer R.A., Maurer A.D., Lau D.C., Auer R.N. Long-term dietary restriction influences plasma ghrelin and GOAT mRNA level in rats. Physiol. Behav. 2010, 99:605-610.
112. Rindi G., Necchi V., Savio A., Torsello A., Zoli M., Locatelli V., Raimondo F., Cocchi D., Solcia E. Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues. Histochem. Cell Biol. 2002, 117:511-519.
113. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1973, 14:125-132.
114. Rocco A., Sarnelli G., Compare D., de Colibus P., Micheli P., Somma P., Marotti B., Cuomo R., Nardone G. Tissue ghrelin level and gastric emptying rate in adult patients with celiac disease. Neurogastroenterol. Motil. 2008, 20:884-890.
115. Saito Y.A., Schoenfeld P., Locke G.R. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am. J. Gastroenterol. 2002, 97:1910-1915.
116. Sakata I., Yang J., Lee C.E., Osborne-Lawrence S., Rovinsky S.A., Elmquist J.K., Zigman J.M. Colocalization of ghrelin O-acyltransferase and ghrelin in gastric mucosal cells. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E134-E141.
117. Sallam H.S., Chen J.D. The prokinetic face of ghrelin. Int. J. Pept. 2010, 2010.
118. Sanger G.J., Alpers D.H. Development of drugs for gastrointestinal motor disorders: translating science to clinical need. Neurogastroenterol. Motil. 2008, 20:177-184.
119. Selimoglu M.A., Altinkaynak S., Ertekin V., Akcay F. Serum ghrelin levels in children with celiac disease. J. Clin. Gastroenterol. 2006, 40:191-194.
120. Serra-Prat M., Fernandez X., Burdoy E., Mussoll J., Casamitjana R., Puig-Domingo M. The role of ghrelin in the energy homeostasis of elderly people: a population-based study. J. Endocrinol. Invest. 2007, 30:484-490.
121. Shin Y.K., Martin B., Kim W., White C.M., Ji S., Sun Y., Smith R.G., Sevigny J., Tschop M.H., Maudsley S., Egan J.M. Ghrelin is produced in taste cells and ghrelin receptor null mice show reduced taste responsivity to salty (NaCl) and sour (citric acid) tastants. PLoS One 2010, 5:e12729.
122. Shintani N., Nakajima T., Okamoto T., Kondo T., Nakamura N., Mayumi T. Involvement of CD4+ T cells in the development of dextran sulfate sodium-induced experimental colitis and suppressive effect of IgG on their action. Gen. Pharmacol. 1998, 31:477-481.
123. Shiotani A., Miyanishi T., Uedo N., Iishi H. Helicobacter pylori infection is associated with reduced circulating ghrelin levels independent of body mass index. Helicobacter 2005, 10:373-378.
124. Sibilia V., Pagani F., Rindi G., Lattuada N., Rapetti D., De Luca V., Campanini N., Bulgarelli I., Locatelli V., Guidobono F., Netti C. Central ghrelin gastroprotection involves nitric oxide/prostaglandin cross-talk. Br. J. Pharmacol. 2008, 154:688-697.
125. Sibilia V., Rindi G., Pagani F., Rapetti D., Locatelli V., Torsello A., Campanini N., Deghenghi R., Netti C. Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action. Endocrinology 2003, 144:353-359.
126. Simren M., Bjornsson E.S., Abrahamsson H. High interdigestive and postprandial motilin levels in patients with the irritable bowel syndrome. Neurogastroenterol. Motil. 2005, 17:51-57.
127. Sjolund K., Ekman R., Wierup N. Covariation of plasma ghrelin and motilin in irritable bowel syndrome. Peptides 2010, 31:1109-1112.
128. Song Y.H., Ma J.Y., Mardh S., Liu T., Sjostrand S.E., Rask L., Borch K., Huang G.C., Barnett P., McGregor A.M., et al. Localization of a pernicious anaemia autoantibody epitope on the alpha-subunit of human H,K-adenosine triphosphatase. Scand. J. Gastroenterol. 1994, 29:122-127.
129. Spitznagel M.B., Benitez A., Updegraff J., Potter V., Alexander T., Glickman E., Gunstad J. Serum ghrelin is inversely associated with cognitive function in a sample of non-demented elderly. Psychiatry Clin. Neurosci. 2010, 64:608-611.
130. Stec-Michalska K., Malicki S., Michalski B., Peczek L., Wisniewska-Jarosinska M., Nawrot B. Gastric ghrelin in relation to gender, stomach topography and Helicobacter pylori in dyspeptic patients. World J. Gastroenterol. 2009, 15:5409-5417.
131. Stengel A., Goebel M., Wang L., Tache Y., Sachs G., Lambrecht N.W. Differential distribution of ghrelin-O-acyltransferase (GOAT) immunoreactive cells in the mouse and rat gastric oxyntic mucosa. Biochem. Biophys. Res. Commun. 2010, 392:67-71.
132. Suzuki H., Masaoka T., Hosoda H., Nomura S., Ohara T., Kangawa K., Ishii H., Hibi T. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio: a possible novel and non-invasive marker for gastric atrophy. Hepatogastroenterology 2004, 51:1249-1254.
133. Tack J., Depoortere I., Bisschops R., Delporte C., Coulie B., Meulemans A., Janssens J., Peeters T. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 2006, 55:327-333.
134. Tack J., Depoortere I., Bisschops R., Verbeke K., Janssens J., Peeters T. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment. Pharmacol. Ther. 2005, 22:847-853.
135. Takamori K., Mizuta Y., Takeshima F., Akazawa Y., Isomoto H., Ohnita K., Ohba K., Omagari K., Shikuwa S., Kohno S. Relation among plasma ghrelin level, gastric emptying, and psychologic condition in patients with functional dyspepsia. J. Clin. Gastroenterol. 2007, 41:477-483.
136. Tanaka-Shintani M., Watanabe M. Distribution of ghrelin-immunoreactive cells in human gastric mucosa: comparison with that of parietal cells. J. Gastroenterol. 2005, 40:345-349.
137. Tatsuguchi A., Miyake K., Gudis K., Futagami S., Tsukui T., Wada K., Kishida T., Fukuda Y., Sugisaki Y., Sakamoto C. Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa. Am. J. Gastroenterol. 2004, 99:2121-2127.
138. Tenore A., Berman W.F., Parks J.S., Bongiovanni A.M. Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease. J. Clin. Endocrinol. Metab. 1977, 44:622-628.
139. Thompson W.G., Heaton K.W., Smyth G.T., Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000, 46:78-82.
140. Tomasetto C., Karam S.M., Ribieras S., Masson R., Lefebvre O., Staub A., Alexander G., Chenard M.P., Rio M.C. Identification and characterization of a novel gastric peptide hormone: the motilin-related peptide. Gastroenterology 2000, 119:395-405.
141. Trudel L., Tomasetto C., Rio M.C., Bouin M., Plourde V., Eberling P., Poitras P. Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 282:G948-G952.
142. Tschop M., Flora D.B., Mayer J.P., Heiman M.L. Hypophysectomy prevents ghrelin-induced adiposity and increases gastric ghrelin secretion in rats. Obes. Res. 2002, 10:991-999.
143. Tsolakis A.V., Portela-Gomes G.M., Stridsberg M., Grimelius L., Sundin A., Eriksson B.K., Oberg K.E., Janson E.T. Malignant gastric ghrelinoma with hyperghrelinemia. J. Clin. Endocrinol. Metab. 2004, 89:3739-3744.
144. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., Taniyama K., Sasaki N., Schlemper R.J. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001, 345:784-789.
145. Ueno H., Shiiya T., Nakazato M. Translational research of ghrelin. Ann. N.Y. Acad. Sci. 2010, 1200:120-127.
146. Van Der Veek P.P., Biemond I., Masclee A.A. Proximal and distal gut hormone secretion in irritable bowel syndrome. Scand. J. Gastroenterol. 2006, 41:170-177.
147. Volante M., Allia E., Gugliotta P., Funaro A., Broglio F., Deghenghi R., Muccioli G., Ghigo E., Papotti M. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J. Clin. Endocrinol. Metab. 2002, 87:1300-1308.
148. Waseem T., Javaid Ur R., Ahmad F., Azam M., Qureshi M.A. Role of ghrelin axis in colorectal cancer: a novel association. Peptides 2008, 29:1369-1376.
149. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., Dhillo W.S., Ghatei M.A., Bloom S.R. Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 2001, 86:5992.
150. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
151. Yang J., Brown M.S., Liang G., Grishin N.V., Goldstein J.L. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 2008, 132:387-396.
152. Yeh A.H., Jeffery P.L., Duncan R.P., Herington A.C., Chopin L.K. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clin. Cancer Res. 2005, 11:8295-8303.
153. Youm Y.H., Yang H., Sun Y., Smith R.G., Manley N.R., Vandanmagsar B., Dixit V.D. Deficient ghrelin receptor-mediated signaling compromises thymic stromal cell microenvironment by accelerating thymic adiposity. J. Biol. Chem. 2009, 284:7068-7077.
154. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., Hsueh A.J. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005, 310:996-999.
155. Zhang W., Chai B., Li J.Y., Wang H., Mulholland M.W. Effect of des-acyl ghrelin on adiposity and glucose metabolism. Endocrinology 2008, 149:4710-4716.